Condensed Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Ordinary Shares and Additional Paid-in Capital	Accumulated Deficit	Accumulated  Other Comprehensive Loss, Net of Tax	Non- controlling Interests
Beginning balance (in shares) at Dec. 31, 2021		214.8
Beginning balance at Dec. 31, 2021	$ 1,158	$ 6,626	$ (1,694)	$ (3,871)	$ 97
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,048		1,023		25
Shares issued - employee stock compensation plans (in shares)		0.9
Shares issued - employee stock compensation plans	(116)	$ (116)
Shares repurchased (in shares)		(2.8)
Shares repurchased	(828)		(828)
Share-based compensation expense	119	$ 119
Dividends to shareholders	(110)		(110)
Net change in fair value of financial instruments	1			1
Net foreign currency translation adjustments	(7)			(6)	(1)
Net postretirement benefit obligation	33			33
Dividends paid to noncontrolling interests on subsidiary common stock	(7)				(7)
Ending balance (in shares) at Mar. 31, 2022		212.9
Ending balance at Mar. 31, 2022	1,291	$ 6,629	(1,609)	(3,843)	114
Beginning balance (in shares) at Dec. 31, 2021		214.8
Beginning balance at Dec. 31, 2021	1,158	$ 6,626	(1,694)	(3,871)	97
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,980
Net change in fair value of financial instruments	(16)
Net foreign currency translation adjustments	(1,119)
Net postretirement benefit obligation	87
Ending balance (in shares) at Sep. 30, 2022		207.6
Ending balance at Sep. 30, 2022	(670)	$ 6,774	(2,638)	(4,919)	113
Beginning balance (in shares) at Mar. 31, 2022		212.9
Beginning balance at Mar. 31, 2022	1,291	$ 6,629	(1,609)	(3,843)	114
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	514		501		13
Shares issued - employee stock compensation plans (in shares)		0.4
Shares issued - employee stock compensation plans	(50)	$ (50)
Shares repurchased (in shares)		(1.7)
Shares repurchased	(500)		(500)
Share-based compensation expense	92	$ 92
Dividends to shareholders	(119)		(119)
Net change in fair value of financial instruments	(9)			(9)
Net foreign currency translation adjustments	(436)			(436)
Net postretirement benefit obligation	28			28
Dividends paid to noncontrolling interests on subsidiary common stock	(23)				(23)
Ending balance (in shares) at Jun. 30, 2022		211.6
Ending balance at Jun. 30, 2022	788	$ 6,671	(1,727)	(4,260)	104
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	418		408		10
Shares issued - employee stock compensation plans (in shares)		0.2
Shares issued - employee stock compensation plans	10	$ 11	(1)
Shares repurchased (in shares)		(4.2)
Shares repurchased	(1,200)		(1,200)
Share-based compensation expense	93	$ 93
Dividends to shareholders	(118)		(118)
Net change in fair value of financial instruments	(8)			(8)
Net foreign currency translation adjustments	(676)			(677)	1
Net postretirement benefit obligation	26			26
Purchases of subsidiary shares from noncontrolling interests	(2)	$ (1)			(1)
Dividends paid to noncontrolling interests on subsidiary common stock	(1)				(1)
Ending balance (in shares) at Sep. 30, 2022		207.6
Ending balance at Sep. 30, 2022	$ (670)	$ 6,774	(2,638)	(4,919)	113
Beginning balance (in shares) at Dec. 31, 2022	205.4	205.4
Beginning balance at Dec. 31, 2022	$ (429)	$ 6,866	(2,772)	(4,623)	100
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,079		1,050		29
Shares issued - employee stock compensation plans (in shares)		0.9
Shares issued - employee stock compensation plans	(132)	$ (131)	(1)
Shares repurchased (in shares)		(1.8)
Shares repurchased	(550)		(550)
Share-based compensation expense	127	$ 127
Dividends to shareholders	(115)		(115)
Net change in fair value of financial instruments	3			3
Net foreign currency translation adjustments	54			54
Net postretirement benefit obligation	22			22
Dividends paid to noncontrolling interests on subsidiary common stock	(1)				(1)
Ending balance (in shares) at Mar. 31, 2023		204.5
Ending balance at Mar. 31, 2023	$ 58	$ 6,862	(2,388)	(4,544)	128
Beginning balance (in shares) at Dec. 31, 2022	205.4	205.4
Beginning balance at Dec. 31, 2022	$ (429)	$ 6,866	(2,772)	(4,623)	100
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,121
Net change in fair value of financial instruments	6
Net foreign currency translation adjustments	(29)
Net postretirement benefit obligation	$ 66
Ending balance (in shares) at Sep. 30, 2023	200.8	200.8
Ending balance at Sep. 30, 2023	$ (486)	$ 7,017	(3,024)	(4,579)	100
Beginning balance (in shares) at Mar. 31, 2023		204.5
Beginning balance at Mar. 31, 2023	58	$ 6,862	(2,388)	(4,544)	128
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	575		560		15
Shares issued - employee stock compensation plans (in shares)		0.4
Shares issued - employee stock compensation plans	(52)	$ (52)
Shares repurchased (in shares)		(1.7)
Shares repurchased	(550)		(550)
Share-based compensation expense	99	$ 99
Dividends to shareholders	(127)		(127)
Net change in fair value of financial instruments	8			8
Net foreign currency translation adjustments	174			174
Net postretirement benefit obligation	24			24
Purchases of subsidiary shares from noncontrolling interests	(2)	$ (1)			(1)
Dividends paid to noncontrolling interests on subsidiary common stock	(45)				(45)
Ending balance (in shares) at Jun. 30, 2023		203.2
Ending balance at Jun. 30, 2023	162	$ 6,908	(2,505)	(4,338)	97
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	467		456		11
Shares issued - employee stock compensation plans (in shares)		0.2
Shares issued - employee stock compensation plans	14	$ 14
Shares repurchased (in shares)		(2.6)
Shares repurchased	(850)		(850)
Share-based compensation expense	95	$ 95
Dividends to shareholders	(125)		(125)
Net change in fair value of financial instruments	(5)			(5)
Net foreign currency translation adjustments	(257)			(256)	(1)
Net postretirement benefit obligation	20			20
Dividends paid to noncontrolling interests on subsidiary common stock	$ (7)				(7)
Ending balance (in shares) at Sep. 30, 2023	200.8	200.8
Ending balance at Sep. 30, 2023	$ (486)	$ 7,017	$ (3,024)	$ (4,579)	$ 100